^
No biomarker
Gallbladder Cancer
GC
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
GemOx
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
gemcitabine
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
GEM-CAP
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
CAPOX
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
XP
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
FP
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
capecitabine
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
5-fluorouracil
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
cisplatin + gemcitabine + albumin-bound paclitaxel
Sensitive: A2 - Guideline
No biomarker
Gallbladder Cancer
5-fluorouracil + oxaliplatin
Sensitive: A2 - Guideline
MSI-H/dMMR
Gallbladder Cancer
dostarlimab
Resistant: C1 - Off-label
HER-2 overexpression
Gallbladder Cancer
trastuzumab
Sensitive: C1 - Off-label
MSI-H/dMMR
Gallbladder Cancer
pembrolizumab
Sensitive: C1 - Off-label
BRCA1 mutation
Gallbladder Cancer
olaparib
Sensitive: C1 - Off-label
MET amplification
Gallbladder Cancer
crizotinib
Sensitive: C3 – Early Trials
ERBB3 mutation
Gallbladder Cancer
lapatinib
Sensitive: C3 – Early Trials
HER-2 amplification
Gallbladder Cancer
trastuzumab
Sensitive: C3 – Early Trials
HER-2 amplification
Gallbladder Cancer
lapatinib
Sensitive: C3 – Early Trials
HER-2 amplification
Gallbladder Cancer
trastuzumab + lapatinib
Sensitive: C3 – Early Trials
ERBB3 mutation
Gallbladder Cancer
trastuzumab
Sensitive: C3 – Early Trials
ERBB3 amplification
Gallbladder Cancer
trastuzumab
Sensitive: C3 – Early Trials
ERBB3 amplification + ERBB3 mutation
Gallbladder Cancer
trastuzumab
Sensitive: C3 – Early Trials
FGFR3-TACC3 fusion
Gallbladder Cancer
Debio 1347
Sensitive: C3 – Early Trials
BRAF L485W
Gallbladder Cancer
BVD-523
Sensitive: C3 – Early Trials
CDKN2A mutation
Gallbladder Cancer
palbociclib
Resistant: C3 – Early Trials
CDKN2A deletion
Gallbladder Cancer
palbociclib
Resistant: C3 – Early Trials
DCK positive
Gallbladder Cancer
gemcitabine
Sensitive: C3 – Early Trials
BRAF D594N
Gallbladder Cancer
encorafenib + binimetinib
Sensitive: C3 – Early Trials
EGFR T790M
Gallbladder Cancer
erlotinib
Sensitive: C4 – Case Studies
BRCA1 Q858
Gallbladder Cancer
olaparib
Resistant: C4 – Case Studies
STK11 K262Sfs*25
Gallbladder Cancer
olaparib
Sensitive: C4 – Case Studies
ATM S1905Ifs*25 + STK11 K262Sfs*25
Gallbladder Cancer
olaparib
Sensitive: C4 – Case Studies
KRAS G12D
Gallbladder Cancer
pembrolizumab
Sensitive: C4 – Case Studies
BRCA1 S451Lfs*20
Gallbladder Cancer
olaparib
Sensitive: C4 – Case Studies
HER-2 S310F
Gallbladder Cancer
lapatinib
Sensitive: C4 – Case Studies